The 8 most recent market catalysts affecting $INO, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 65
Jefferies Upgrades Inovio Pharmaceuticals to Buy, Raises Price Target to $3
Jefferies analyst Roger Song upgraded Inovio Pharmaceuticals (INO) from a 'Hold' to a 'Buy' rating and significantly raised the price target from $1.80 to $3.00. This positive re-e…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 75
Inovio Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 EPS results.
This headline represents a strong corporate catalyst for Inovio Pharmaceuticals, driving its share price higher. Better-than-expected earnings often signal efficient operations, su…
Aug 12, 2026
Corporate Catalyst
Bearish
Impact 92
Inovio Pharmaceuticals Q2 EPS $(0.07) Beats $(0.22) Estimate
Inovio Pharmaceuticals (INO) announced Q2 EPS of $(0.07), significantly outperforming the analyst estimate of $(0.22). This 68.18% beat, coupled with an 88.52% improvement over las…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 75
Inovalis REIT Q2 FFO $(0.01) Beats $(0.10) Estimate, Sales $2.934M Down From $4.419M YoY
Inovalis REIT's Q2 earnings report presents a mixed picture. While the company's FFO loss of $(0.01) per share significantly beat the analyst consensus of $(0.10), indicating bette…
Aug 3, 2026
Corporate Catalyst
Bearish
Impact 65
Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Lowers Price Target to $4
Piper Sandler's reiteration of an 'Overweight' rating suggests the analyst still sees upside potential for Inovio Pharmaceuticals, but the simultaneous reduction in the price targe…
Jul 30, 2026
Corporate Catalyst
Neutral
Impact 85
Reported Earlier, INOVIO Prices $20.0M Public Offering Of 21,052,632 Common Shares At $0.95 Per Share With Accompanying Warrants
This public offering is a significant corporate catalyst for INOVIO. The issuance of over 21 million new shares at a price below the market value (implied by the $20M total) will l…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 85
Inovio Stock Falls 21% After Hours: Here's What's Going On
Inovio Pharmaceuticals (INO) priced a public offering of 21.05 million shares and 42.11 million warrants at $0.95 per unit, aiming to raise $20 million. This move, while securing c…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 65
INOVIO Pharmaceuticals Announces Proposed Public Offering Of Shares And Warrants
INOVIO Pharmaceuticals is seeking to raise capital through a public offering of its common stock and warrants. This type of offering typically leads to dilution for current shareho…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.